Net Income
Net Income
Bristol-Myers Squibb Net Income increased by 146.3% to $2.68B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.0%, from $2.46B to $2.68B. Over 4 years (FY 2021 to FY 2025), Net Income shows relatively stable performance with a 0.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionNet Income
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
Consistent growth in net income is the primary driver of long-term stock price appreciation and dividend capacity.
Detailed definition
The 'bottom line' profit of the company after all expenses, including interest and taxes, have been deducted from total...
Peer comparison
This is the standard metric for calculating Earnings Per Share (EPS) and Price-to-Earnings (P/E) ratios.
Metric ID:
net_incomeHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.06B | $1.55B | $2.37B | $1.28B | $1.42B | $1.61B | $2.02B | $2.26B | $2.07B | $1.93B | $1.76B | -$11.91B | $1.68B | $1.21B | $0.00 | $2.46B | $1.31B | $2.20B | $1.09B | $2.68B |
| QoQ Change | — | +46.5% | +53.4% | -46.1% | +11.2% | +13.0% | +25.9% | +11.9% | -8.4% | -7.0% | -8.6% | -776.0% | +114.1% | -27.9% | -100.0% | — | -46.7% | +68.0% | -50.6% | +146.3% |
| YoY Change | — | — | — | — | +34.7% | +3.9% | -14.8% | +77.0% | +45.9% | +20.0% | -12.9% | -626.6% | -19.0% | -37.2% | -100.0% | +120.6% | -22.0% | +81.8% | — | +9.0% |
Range-$11.91B – $2.68B
CAGR+21.7%
Avg YoY Growth-29.3%
Median YoY Growth+3.9%
Net Income at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's net income?
- Bristol-Myers Squibb (BMY) reported net income of $2.68B in Q1 2026.
- How has Bristol-Myers Squibb's net income changed year-over-year?
- Bristol-Myers Squibb's net income increased by 9.0% year-over-year, from $2.46B to $2.68B.
- What is the long-term trend for Bristol-Myers Squibb's net income?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's net income has grown at a 0.2% compound annual growth rate (CAGR), from $6.99B to $7.05B.
- What does net income mean?
- The final profit of the company after every single expense and tax has been paid.